The A640G CYBA polymorphism associates with subclinical atherosclerosis in diabetes

Frontiers in Bioscience - Elite

Volumn 3 E, Issue 4, 2011, Pages 1467-1474

  De Ujue Moreno, Maria ^a   Jose, Gorka San ^a   Fortuno, Ana ^a   Miguel Carrasco, Jose Luis ^a   Beloqui, Oscar ^b   Diez, Javier ^a,b   Zalba, Guillermo ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

A640G polymorphism; Atherosclerosis; Diabetes; Intima media thickness; NADPH oxidase; Oxidative stress

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; CYBA PROTEIN, HUMAN;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYBA GENE; DIABETIC PATIENT; DISEASE MARKER; DNA POLYMORPHISM; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN CELL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PREVALENCE; RISK ASSESSMENT; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; PHENOTYPE;

ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; NADPH OXIDASE; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 80053579227     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Beckman, J. A., M. A. Creager and P. Libby: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA, 287, 2570-81 (2002) (Pubitemid 34517204)
2. Kaneto, H., N. Katakami, D. Kawamori, T. Miyatsuka, K. Sakamoto, T. A. Matsuoka, M. Matsuhisa and Y. Yamasaki: Involvement of oxidative stress in the pathogenesis of diabetes. Antioxid Redox Signal, 9, 355-66 (2007) (Pubitemid 46145981)
3. Cai, H. and D. G. Harrison: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res, 87, 840-4 (2000)
4. Djaberi, R., J. D. Schuijf, E. J. De Koning, T. J. Rabelink, J. W. Smit, L. J. Kroft, A. M. Pereira, A. J. Scholte, M. Spaans, J. A. Romijn, A. De Roos, E. E. Van der Wall, J. W. Jukema and J. J. Bax: Usefulness of carotid intima-media thickness in patients with diabetes mellitus as a predictor of coronary artery disease. Am J Cardiol, 104, 1041-6 (2009)
5. Bots, M. L., A. W. Hoes, P. J. Koudstaal, A. Hofman and D. E. Grobbee: Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation, 96, 1432-7 (1997) (Pubitemid 27375333)
6. Guzik, T. J., S. Mussa, D. Gastaldi, J. Sadowski, C. Ratnatunga, R. Pillai and K. M. Channon: Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD (P) H oxidase and endothelial nitric oxide synthase. Circulation, 105, 1656-62 (2002) (Pubitemid 34298608)
7. Kim, Y. K., M. S. Lee, S. M. Son, I. J. Kim, W. S. Lee, B. Y. Rhim, K. W. Hong and C. D. Kim: Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. Diabetes, 51, 522-7 (2002) (Pubitemid 34764812)
8. Zhang, L., A. Zalewski, Y. Liu, T. Mazurek, S. Cowan, J. L. Martin, S. M. Hofmann, H. Vlassara and Y. Shi: Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation, 108, 472-8 (2003) (Pubitemid 36935542)
9. Hayek, T., M. Kaplan, R. Kerry and M. Aviram: Macrophage NADPH oxidase activation, impaired cholesterol fluxes, and increased cholesterol biosynthesis in diabetic mice: a stimulatory role for D-glucose. Atherosclerosis, 195, 277-86 (2007) (Pubitemid 350087956)
10. Avogaro, A., E. Pagnin and L. Calo: Monocyte NADPH oxidase subunit p22 (phox) and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: relationship with oxidative stress. J Clin Endocrinol Metab, 88, 1753-9 (2003) (Pubitemid 36623400)
11. Ushio-Fukai, M., A. M. Zafari, T. Fukui, N. Ishizaka and K. K. Griendling: p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem, 271, 23317-21 (1996) (Pubitemid 26314775)
12. Adaikalakoteswari, A., M. Balasubramanyam, M. Rema and V. Mohan: Differential gene expression of NADPH oxidase (p22phox) and hemoxygenase-1 in patients with Type 2 diabetes and microangiopathy. Diabet Med, 23, 666-74 (2006) (Pubitemid 43830069)
13. San Jose, G., A. Fortuño, O. Beloqui, J. Diez and G. Zalba: NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases. Clin Sci (Lond), 114, 173-82 (2008) (Pubitemid 351293993)
14. De Boer, M., A. De Klein, J. P. Hossle, R. Seger, L. Corbeel, R. S. Weening and D. Roos: Cytochrome b558-negative, autosomal recessive chronic granulomatous disease: two new mutations in the cytochrome b558 light chain of the NADPH oxidase (p22-phox). Am J Hum Genet, 51, 1127-35 (1992)
15. Gardemann, A., P. Mages, N. Katz, H. Tillmanns and W. Haberbosch: The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals. Atherosclerosis, 145, 315-23 (1999) (Pubitemid 29359140)
16. Inoue, N., S. Kawashima, K. Kanazawa, S. Yamada, H. Akita and M. Yokoyama: Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation, 97, 135-7 (1998) (Pubitemid 28124668)
17. Zafari, A. M., M. N. Davidoff, H. Austin, L. Valppu, G. Cotsonis, B. Lassegue and K. K. Griendling: The A640G and C242T p22 (phox) polymorphisms in patients with coronary artery disease. Antioxid Redox Signal, 4, 675-80 (2002) (Pubitemid 35001452)
18. Zalba, G., O. Beloqui, G. San Jose, M. U. Moreno, A. Fortuño and J. Diez: NADPH oxidase-dependent superoxide production is associated with carotid intimamedia thickness in subjects free of clinical atherosclerotic disease. Arterioscler Thromb Vasc Biol, 25, 1452-7 (2005) (Pubitemid 40923367)
19. San Jose, G., M. U. Moreno, S. Olivan, O. Beloqui, A. Fortuño, J. Diez and G. Zalba: Functional effect of the p22phox-930A/G polymorphism on p22phox expression and NADPH oxidase activity in hypertension. Hypertension, 44, 163-9 (2004) (Pubitemid 39014233)
20. The International HapMap Consortium. The International HapMap Project. Nature, 426, 789-96 (2003)
21. Hodgkinson, A. D., B. A. Millward and A. G. Demaine: Association of the p22phox component of NAD (P) H oxidase with susceptibility to diabetic nephropathy in patients with type 1 diabetes. Diabetes Care, 26, 3111-5 (2003) (Pubitemid 37339506)
22. Guzik, T. J., N. E. West, E. Black, D. McDonald, C. Ratnatunga, R. Pillai and K. M. Channon: Vascular superoxide production by NAD (P) H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res, 86, E85-90 (2000)
23. Zalba, G., A. Fortuño, J. Orbe, G. San Jose, M. U. Moreno, M. Belzunce, J. A. Rodriguez, O. Beloqui, J. A. Paramo and J. Diez: Phagocytic NADPH oxidasedependent superoxide production stimulates matrix metalloproteinase-9: implications for human atherosclerosis. Arterioscler Thromb Vasc Biol, 27, 587-93 (2007)
24. Inoguchi, T., P. Li, F. Umeda, H. Y. Yu, M. Kakimoto, M. Imamura, T. Aoki, T. Etoh, T. Hashimoto, M. Naruse, H. Sano, H. Utsumi and H. Nawata: High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD (P) H oxidase in cultured vascular cells. Diabetes, 49, 1939-45 (2000)
25. Mohanty, P., W. Hamouda, R. Garg, A. Aljada, H. Ghanim and P. Dandona: Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab, 85, 2970-3 (2000) (Pubitemid 32269184)
26. San Jose, G., J. Bidegain, P. A. Robador, J. Diez, A. Fortuño and G. Zalba: Insulin-induced NADPH oxidase activation promotes proliferation and matrix metalloproteinase activation in monocytes/macrophages. Free Radic Biol Med, 46, 1058-67 (2009)
27. Ceolotto, G., M. Bevilacqua, I. Papparella, E. Baritono, L. Franco, C. Corvaja, M. Mazzoni, A. Semplicini and A. Avogaro: Insulin generates free radicals by an NAD (P) H, phosphatidylinositol 3'-kinase-dependent mechanism in human skin fibroblasts ex vivo. Diabetes, 53, 1344-51 (2004) (Pubitemid 38569022)
28. Wyche, K. E., S. S. Wang, K. K. Griendling, S. I. Dikalov, H. Austin, S. Rao, B. Fink, D. G. Harrison and A. M. Zafari: C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension, 43, 1246-51 (2004) (Pubitemid 38696914)
29. Mehranpour, P., S. S. Wang, R. R. Blanco, W. Li, Q. Song, B. Lassegue, S. I. Dikalov, H. Austin and A. M. Zafari: The C242T CYBA polymorphism as a major determinant of NADPH oxidase activity in patients with cardiovascular disease. Cardiovasc Hematol Agents Med Chem, 7, 251-9 (2009)
30. Moreno, M. U., G. San Jose, A. Fortuño, O. Beloqui, J. Diez and G. Zalba: The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension. J Hypertens, 24, 1299-306 (2006) (Pubitemid 43948329)
31. Kawamori, R., Y. Yamasaki, H. Matsushima, H. Nishizawa, K. Nao, H. Hougaku, H. Maeda, N. Handa, M. Matsumoto and T. Kamada: Prevalence of carotid atherosclerosis in diabetic patients. Ultrasound highresolution B-mode imaging on carotid arteries. Diabetes Care, 15, 1290-4 (1992)
32. Yamasaki, Y., R. Kawamori, H. Matsushima, H. Nishizawa, M. Kodama, Y. Kajimoto, T. Morishima and T. Kamada: Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes, 43, 634-9 (1994) (Pubitemid 24138774)
33. Yamasaki, Y., R. Kawamori, H. Matsushima, H. Nishizawa, M. Kodama, M. Kubota, Y. Kajimoto and T. Kamada: Asymptomatic hyperglycaemia is associated with increased intimal plus medial thickness of the carotid artery. Diabetologia, 38, 585-91 (1995)
34. Katakami, N., H. Kaneto, T. A. Matsuoka, M. Takahara, K. Imamura, F. Ishibashi, T. Kanda, K. Kawai, T. Osonoi, A. Kashiwagi, R. Kawamori, M. Matsuhisa, I. Shimomura and Y. Yamasaki: Accumulation of gene polymorphisms related to oxidative stress is associated with myocardial infarction in Japanese type 2 diabetic patients. Atherosclerosis, 212, 534-538 (2010)
35. Hayaishi-Okano, R., Y. Yamasaki, Y. Kajimoto, K. Sakamoto, K. Ohtoshi, N. Katakami, D. Kawamori, T. Miyatsuka, M. Hatazaki, Y. Hazama and M. Hori: Association of NAD (P) H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes. Diabetes Care, 26, 458-63 (2003) (Pubitemid 36929073)
36. Moreno, M. U. and G. Zalba: CYBA gene variants as biomarkers for coronary artery disease. Drug News Perspect, 23, 316-24 (2010)
37. Ceriello, A., N. Bortolotti, E. Falleti, C. Taboga, L. Tonutti, A. Crescentini, E. Motz, S. Lizzio, A. Russoand and E. Bartoli: Total radical-trapping antioxidant parameter in NIDDM patients. Diabetes Care, 20, 194-7 (1997) (Pubitemid 27051562)
38. Vericel, E., C. Januel, M. Carreras, P. Moulinand and M. Lagarde: Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status. Diabetes, 53, 1046-51 (2004) (Pubitemid 38436617)